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Abstract
Background: Endothelial-to-mesenchymal transition (EndoMT) is a crucial event during kidney interstitial fibrosis
and it is believed to be inhibited by netrin-1. Our aim was to determine the influence of netrin-1 on renal EndoMT
in chronic kidney disease by studying its effect in 5/6 nephrectomized (Nx) rats.
Methods: Male Sprague–Dawley rats were divided into three groups (10 rats/group): sham-operated rats treated with
control adenovirus; 5/6 Nx rats treated with control adenovirus; and 5/6 Nx rats treated with recombinant adenovirus
expressing the netrin-1 gene (Ad-netrin-1). Rats were sacrificed 13 weeks after surgery. Blood urea nitrogen (BUN) and
serum creatinine (Scr) levels were measured regularly after surgery. After the rats were sacrificed, pathological changes
in renal tissues were analyzed histologically. Immunofluorescence was performed to evaluate the co-expression of
CD31 and α-SMA. CD31, α-SMA and Snail mRNA were detected by RT-PCR. Protein expression was detected by
western blot.
Results: Renal function and histopathological damage were significantly improved in Ad-netrin-1-treated 5/6
Nx rats. In the sham and control-treated 5/6 Nx rats, the percentage of CD31+/α-SMA+ cells increased, which
indicated EndoMT. However, the percentage of CD31+/α-SMA+ cells were reduced in the netrin-1-treated 5/6
Nx rats, which indicates netrin-1-induced blocking of EndoMT.
Conclusion: From the results, it seems that netrin-1 attenuates the progression of renal dysfunction by inhibiting
EndoMT in 5/6 Nx rats. Netrin-1 can therefore be considered as a potential therapeutic agent for the treatment of
renal fibrosis.
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Background
Interstitial fibrosis has long been viewed as a common
feature of chronic kidney disease (CKD), and it is a char-
acteristic hallmark that indicates the prognosis of any
kind of progressive kidney disease. Interstitial fibrosis
may occur diffusely, with or without atrophic tubules, or
focally, in association with atrophic tubules. The transi-
tion of renal epithelial cells to myofibroblasts in renal fi-
brosis has been intensively investigated, and increasing
evidence suggests that the contribution of epithelial-
mesenchymal transition (EMT) to the pool of activated
fibroblasts is responsible for renal interstitial fibrosis in
several experimental models [1–3].
Endothelial-mesenchymal transition (EndoMT) has
emerged as another potentially important mechanism that
is involved in both the developmental and pathological
processes of kidney interstitial fibrosis. EndoMT is a
complex process via which certain endothelial cells lose
their endothelial characteristics and transform into mes-
enchymal or smooth muscle cells (SMCs) [4]. Fibroblasts
are likely to be of endothelial origin, so it is possible that
EndoMT contributes substantially to the accumulation of
fibroblasts in the development and progression of renal
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fibrosis. EndoMT was first investigated as a critical
process in heart development, and studies have shown
that EndoMT contributes to the development of diabetic
renal interstitial fibrosis, diabetic nephropathy, and cardiac
fibrosis, which indicates a relationship between EndoMT
and fibrosis [5–7] . Moreover, a recent study has demon-
strated that EndoMT can contribute to the progression of
multiple diseases in mouse models of CKD [8]. Further,
EndoMT is known to contribute to the accumulation of
activated fibroblasts and myofibroblasts in fibrotic kidneys
[8]. However, the mechanism via which EndoMT affects
fibrosis remains largely unknown.
Netrin-1 is a laminin-related secreted protein that is
widely expressed in many tissues, including renal tissues.
In recent studies, netrin-1 was shown to play a role in
the migration of vascular endothelial cells and accelerat-
ing angiogenesis [9, 10], tumor progression, and growth
and regulation of inflammation [11–13]. In particular,
dysregulation of netrin-1 after ischemia contributes to
the development of renal failure; further, studies indicate
that downregulation of netrin-1 in vascular endothelial
cells may promote endothelial cell activation and infil-
tration of leukocytes into the kidney, thereby enhancing
tubular injury [14]. Netrin-1 is also known to regulate
inflammatory cell migration and their functions in many
diseases and suppress acute kidney injury (AKI) [15].
However, whether netrin-1 is associated with the anti-
EndoMT mechanisms in CKDs is still unknown.
In this study, we investigated whether EndoMT occurs
in 5/6 nephrectomized (Nx) rats and whether it contrib-
utes to the development of renal interstitial fibrosis. This
model is often used to study the mechanisms of and
potential therapeutic approaches to progression of CKD
with renal reduction [16]. Meanwhile, we assessed the
effect of netrin-1 on renal EndoMT in order to deter-
mine whether it provides protection against renal dys-
function in 5/6 Nx rats.
Methods
Construction of a recombinant netrin-1-expressing
adenovirus
A netrin-1-expressing adenovirus was created using the
AdEasy Vector system (Qbiogene, Nottingham, UK) as
previously described [17] . The PacI-linearized recom-
binant plasmid was then transfected into HEK293 cells
(ATCC, Manassas, VA, USA). Adenovirus titers were
determined by a plaque-forming assay, and expressed
as the number of plaque-forming units (PFU). Virus
stocks were amplified by culturing HEK293 cells with
low-passage virus stocks, and amplification was contin-
ued until the titer reached 1010 PFU/ml. Aliquots of
recombinant adenoviruses were then frozen at−80 °C
until further use.
Animals and experimental protocol
All animal procedures were conducted according to the
animal care and ethics laws and were approved by the
Animal Care Committee of the General Hospital of
Shenyang Military Area Command. The 5/6 Nx rat
model of chronic renal failure was established according
to the method published by Ghosh et al. [18]. Thirty
male Sprague–Dawley rats (8–10 weeks old, weighing
250–300 g) were obtained from the General Hospital
of Shenyang Military Area Command Animal Centre
(Shenyang, China), and maintained at 22 ± 1 °C, with
relative air humidity at 60 ± 5 % and with free access
to food and water. They were then randomly divided
into one of three groups (n = 10 rats/group): sham-
operated rats treated with the control adenovirus
(empty vector); 5/6 Nx rats treated with the control
adenovirus (empty vector); and 5/6 Nx rats treated
with the netrin-1-expressing recombinant adenovirus
(Ad-netrin-1). The rats in the sham-operated group
were anesthetized by intraperitoneal injection of 10 %
chloral hydrate (3 ml/kg) followed by surgical expos-
ure and removal of the renal capsule. The 5/6 Nx rats
first underwent a partial left nephrectomy (removal of
1/3 of the superior pole and 1/3 of the inferior pole)
under anesthesia. The animals were then returned to
the vivarium to recover. One week later, they under-
went a total right nephrectomy, thus accomplishing a
5/6 nephrectomy. During the second surgery, the 5/6 Nx
rats were injected with 1 × 108 PFU of control adenovirus
(empty vector) or Ad-netrin-1 via the vena caudalis as re-
ported in previous studies [19]. All animals were sacrificed
at the 13th week of the experiment, by an intraperitoneal
injection of sodium pentobarbital (50 mg/kg). Blood and
kidney tissues were immediately collected and kept at
−80 °C for further analysis.
Biochemical analyses
Blood samples were collected from all animals at weeks
12 after surgery, for analysis of blood urea nitrogen
(BUN) and serum creatinine (Scr). BUN and Scr concen-
trations were assayed with an Olympus 400 clinical
chemistry analyzer.
Renal tissues were fixed in 4 % buffered paraformalde-
hyde and then embedded in paraffin. Then, 4-μm thick
sections were generated and stained with hematoxylin
and eosin (H&E) and Masson’s trichrome. The H&E-
stained slices were examined by optical microscopy for
pathological changes, and the slides stained with
Masson’s trichrome were analyzed for interstitial fibrosis
as previously described [20]. To determine the percent-
age of interstitial space in the kidney, five consecutive
fields were randomly selected in the renal cortex and
evaluated under a 400× lens on a 10 × 10 grid-imprinted
reticule. All points not counted within tubular cells, lumen,
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glomerulus, or vascular spaces were considered as intersti-
tial points. This fraction represented the relative interstitial
volume. Results were expressed as percentages of the mea-
sured area, representing the interstitial space and being the
relative volume of the interstitium.
Immunofluorescence analysis
Frozen tissues were cut into 4-μm thick sections and fixed
in 100 % acetone at−20 °C for 10 min. After washing with
phosphate-buffered saline and blocking with 5 % bovine
serum albumin (BSA) for 1 h, the tissues were incubated
with primary antibodies specific for CD31 (Santa Cruz
Biotechnology, Europe) and α-SMA (Abcam, England) at
4 °C overnight. The tissues were then incubated with a
mixture of two secondary antibodies that had been raised
in different species and conjugated to different fluoro-
chromes (fluorescein isothiocyanate-conjugated goat anti-
mouse and Cy3-conjugated goat anti-rabbit), and were
incubated in 1 % BSA for 1 h at room temperature in the
dark. For the negative control experiments, the primary
antibody was replaced with non-immune IgG, which pro-
vided minimal labeling. Images were captured using an
LSM5 Image Browser (Zeiss) and analyzed using a laser
scanning confocal microscope (LSM 510 META, Zeiss).
The areas showing CD31 and α-SMA immunoreaction
were measured, and fluorescence intensity was analyzed
as previously described [21].
Real-time PCR
Frozen tissue samples were lysed in TRIzol reagent
(Invitrogen, Carlsbad, CA), and total RNA was extracted
according to the manufacturer’s instructions. The levels
of transcripts were determined by real-time PCR (RT-
PCR) using SYBR ®Premix Ex Taq ™ II (TaKaRa, Shiga,
Japan) on an ABI 7901HT series PCR cycler (Applied
Biosystems, Foster City, CA, USA). The data were normal-
ized to β-actin expression and further normalized to the
negative control. Primers were obtained from Sangon Bio-
logical Engineering Technology and Services (Shanghai,
China), and the following specific primers were designed:
β-actin, 5′-CCCACTCTTCCACCT TTG-3′ (sense) and
5′-TAGCCATATTCATTGTCATACC-3′ (antisense); CD31,
5′-CTCCATCCTGTCGGGTAA-3′ (sense) and 5′-TCATT
CACGGTTTCTTCG-3′ (antisense); α-SMA, 5′- GGC
AACCTCAAGAAGTCCC−3′ (sense) and 5′- GTGCA
GCCATCCACAAGC−3′ (antisense); Snail,5′-GGCTG
ATGGAAGGCAGAG−3′ (sense) and 5′- CCAGTGG
GTTGGCTTTAGTT−3′ (antisense).
Fig. 1 Changes in the blood urea nitrogen (BUN) and serum creatinine (Scr) levels in rats . From the seventh week after surgery, a significant increase
in the Scr and BUN level was observed in the 5/6 Nx groups with and without Ad-netrin-1 treatment, in comparison with the sham-operated group.
At postsurgery weeks 7 and 12, the rats that received Ad-netrin-1 had significantly lower BUN and Scr levels than the 5/6 Nx rats administered the
control adenovirus. *, P < 0.05 vs. sham; #, P < 0.05 vs. 5/6 Nx
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Western blotting
Total protein was extracted from tissue samples with a
commercial kit (GE healthcare Biosciences, Pittsburg, PA,
USA). The protein concentrations in the lysates were
assayed by the BCA assay using commercial kits (Invitro-
gen). According to the assay results, the lysates were
adjusted to a protein concentration of 1 g/l and kept in
Eppendorf tubes (35 μl/tube) at−70 °C before subsequent
use. The protein (40 μg) obtained from each lysate was
electrophoresed in a gel containing 8 % sodium dodecyl
sulfate. The separated fractions were transferred to a
nitrocellulose membrane, treated with skimmed milk for
2 h to block non-specific antibody-binding sites, rinsed
with Tris-buffered saline (TBS), and incubated overnight
at 4 °C with primary antibodies specific to Snail (1:1000;
Cell Signaling Technology, Beverly, Massachusetts), CD31
(1:1000; Santa Cruz Biotechnology, Europe) and α-SMA
(1:500; Abcam, England). After rinsing with TBS (10 min,
three times each), the membrane was incubated with a
horseradish peroxidase-labeled secondary antibody (1:50
00; Sigma-Aldrich Co.) at room temperature for 1 h,
rinsed with TBST (Tris-buffered saline with 10 % Tween-
20) and developed using the enhanced chemiluminescence
kit (ECL, GE Healthcare Biosciences). Equal protein load-
ing was confirmed by immunostaining against β-actin
(1:4000; Sigma-Aldrich Co). The membrane was imaged
and analyzed with a Multimage Light Cabinet (Alpha
Innotech Corp., San Leandro, California).
Fig. 2 Histological findings at postoperative week 13. Hematoxylin and eosin staining a and Masson’s trichrome staining b in the renal tissue of
sham-operated rats treated with control adenovirus (a), 5/6 Nx rats treated with control adenovirus (b) and 5/6 Nx rats treated with Ad-netrin-1
(c; original magnification: 400×). Quantification of the percentage of interstitial space c in the kidney is presented in a bar chart; the relative
interstitial volume was quantified by morphometric analysis of Masson trichrome-stained kidney sections in each group; all results are expressed
as mean ± SEM; *, P < 0.05 vs. sham. #, P < 0.05 vs. 5/6 Nx group; n = 10 for each group
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ELISA studies TGF-β
Transforming growth factor (TGF)-β serum levels were
determined by ELISA (R&D Systems) according to the
manufacturer’s instructions. ELISA results were read on
a Fusion from PerkinElmer (Boston, MA).
Statistical analyses
The data were analyzed by analysis of variance
(ANOVA) using the SPSS 15.0 (SPSS, Chicago, IL, USA)
software and are expressed as mean ± standard deviation
(SD). The results were considered significant at P < 0.05.
Results
Netrin-1 attenuates the progression of renal dysfunction
in 5/6 Nx rats
Our previous studies showed that the 5/6 Nx group had
substantially reduced netrin-1 expression compared with
the sham-operated group, and that netrin-1 was not de-
tectable in the interstitial space. The Ad-netrin-1-treated
5/6 Nx group showed substantially increased netrin-1
expression compared with the 5/6 Nx group [17].
To determine the role of netrin-1 in CKD, renal function
was determined by measuring BUN and Scr in all three
groups of rats. As expected, the 5/6 Nx rats (n = 10) had
significant elevations of Scr and BUN. The BUN and Scr
levels were significantly increased in the 5/6 Nx groups
compared with the sham-operated group (n = 10) at 7 weeks
and 12 weeks; however, Ad-netrin-1 treatment (n = 10) had
a significantly beneficial effect on reducing Scr and BUN
levels (Fig. 1, P < 0.05). In H&E-stained images of kidney
sections, the kidneys of the sham-operated rats showed no
significant pathologic changes (Fig. 2, n = 10). However,
focal interstitial fibrosis with tubular dilatation and shrink-
age was observed in the vehicle-treated 5/6 Nx group. The
pathological changes were alleviated in the Ad-netrin-1-
treated 5/6 Nx group. Masson staining showed that the
area of interstitial fibrosis in the vehicle-treated 5/6 Nx
group was significantly greater than that in the sham-
operated group. A smaller interstitial space was observed in
the Ad-netrin-1-treated 5/6 Nx group. These data suggest
that netrin-1 protected renal function in the 5/6 Nx rats.
Netrin-1 attenuates EndoMT in 5/6 Nx rats
Previous studies have shown that EndoMT contributes
to the accumulation of fibroblasts in tumors [22].
Here, we tested the hypothesis that EndoMT occurs
in 5/6 Nx rat.
Renal tissues from the sacrificed rats were double-
labeled using antibodies against the endothelial marker
CD31 and the fibroblast marker α-SMA, which are indi-
cators of EndoMT. Confocal microscopy revealed colo-
calization of CD31 and α-SMA (Fig. 3). Further, we
observed that CD31 immunoreactivity decreased and
some CD31-positive vessels acquired α-SMA staining in
the vehicle-treated 5/6 Nx rats compared with sham-
operated rats. α-SMA positive fibroblast populations
were substantially increased in the 5/6 Nx rats compared
with the sham-operated controls, which suggests that
EndoMT had occurred in 5/6 Nx rats. The administra-
tion of Ad-netrin-1 markedly reduced the number of
Fig. 3 Netrin-1-induced inhibition of EndoMT in 5/6 Nx rats, as assessed by laser scanning confocal microscopy. Representative immunofluorescence
images showing CD31 (green) and α-SMA (red) labeling. Double-positive renal cells were detected in the sham-operated group, and 5/6 Nx groups
with and without Ad-netrin-1 treatment. The administration of netrin-1 reversed these effects (P < 0.05). The experiments were repeated three times
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CD31+/α-SMA+ double-labeled cells in the Ad-netrin-
1-treated 5/6 Nx rats. EndoMT involves a progressive
loss of the endothelial cell marker CD31 associated with
a reciprocal gain of the mesenchymal marker α-SMA.
These findings suggest that EndoMT may account for a
considerable portion of the fibroblasts in 5/6 Nx rats,
and that EndoMT can be attenuated by netin-1.
Netrin-1 affects the mRNA and protein expression of
CD31, α-SMA and snail
Next we investigated the expression levels of CD31 and
α-SMA in renal tissues by Western blotting and real-
time PCR. Mesenchymal mRNA and protein expression
profiles showed increased expression of α-SMA and de-
creased expression of the endothelial marker CD31 in the
vehicle-treated 5/6 Nx group compared with the sham-
operated group (Fig. 4, P < 0.05). However, α-SMA expres-
sion was markedly decreased and CD31 expression was
increased in the Ad-netrin-1-treated 5/6 Nx group com-
pared with the vehicle-treated 5/6 Nx group. There are a
number of key factors required for EndoMT. These in-
clude Snail and E-cadherin. Snail is a master regulator
of EndoMT and can repress E-cadherin expression [23].
Snail levels were up-regulated in the 5/6 Nx rats. This
Fig. 4 Expression of CD31, α-SMA and Snail in the kidney. a CD31 and α-SMA mRNA expression was quantified by real-time PCR and normalized to
β-actin mRNA expression in the kidney tissues of sham-operated rats treated with the control adenovirus at postoperative week 13 (sham), 5/6 Nx
rats treated with the control adenovirus (5/6 Nx), and 5/6 Nx rats treated with Ad-netrin-1 (5/6 Nx + netrin-1). b A representative western blot of the
proteins extracted from the three experimental groups, indicating the level of CD31 and α-SMA protein expression relative to β-actin. c Relative
expression of Snail mRNA was determined by realtime RT-PCR and normalized to β-actin mRNA (left panel). Snail protein levels were assessed by
Western blot (right panel). All data are expressed as mean ± SEM; *, P < 0.05 vs. sham; #, P < 0.05 vs. 5/6 Nx
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was down-regulated following administration of netrin-
1. These findings indicate disruption of EndoMT by
Netrin-1 in 5/6 Nx rats.
Netrin-1 affects TGF-β expression
TGF-β is a potent inducer of endothelial to mesenchy-
mal transitions. In addition, it is important in EndoMT.
We investigated the expression levels of TGF-β by
ELISA. The serum of the vehicle-treated 5/6 Nx group
showed stronger TGF-β expression compared to the
sham-operated group; however, TGF-β expression in the
Ad-netrin-1-treated 5/6 Nx group was significantly de-
creased compared with the vehicle-treated 5/6 Nx group
(Fig. 5, P < 0.05). These findings indicate that Netrin-1
repressed TGF-β expression in the 5/6 Nx rats.
Discussion
In our previous study [17], we reported that netrin-1 ap-
pears to be mediated by preservation of PTC endothelium
and is associated with partial reversal of impaired angio-
genesis, which reduce renal fibrosis in the 5/6 Nx rat
model of kidney disease. Other work had demonstrated
that EndoMT contributes to the early development of
renal interstitial fibrosis in mice with streptozotocin
(STZ)-induced diabetes [24]. Based on these findings, we
concluded that netrin-1 plays an important role in
EndoMT in 5/6 Nx rats. In the present study, using
netrin-1-expressing adenovirus, we have provided evi-
dence for the role of netrin-1 in EndoMT that occurs in
CKD by showing that netrin-1 can prevent renal dysfunc-
tion and attenuate the process of EndoMT in the 5/6 Nx
rat model. CKD is histologically characterized by intersti-
tial fibrosis, which may be driven by peritubular capillary
dropout and hypoxia. In kidney fibrosis, EndoMT is an
important mechanism contributing to the accumulation
of activated fibroblasts and myofibroblasts. In this study,
we found evidence for potential EndoMT states in 5/6 Nx
rats, which are a well-established model of CKD. EndoMT
was assessed based on the expression of α-SMA in cells
carrying the endothelial-specific cell surface marker CD-
31 in the vehicle-treated 5/6 Nx rats. In support of this, it
has been reported that co-expression of the endothelial
cell marker CD31 and fibroblast marker α-SMA in the
endothelium is indicative of an early stage of EndoMT [6].
Our study found that netrin-1 pretreatment resulted
in blocking of EndoMT in 5/6 Nx rats; however, the
mechanism via which netrin-1 attenuates renal fibrosis
by blocking EndoMT remains largely unknown. Studies
have demonstrated that TGF-β, bone morphogenic pro-
tein (BMP), and the Notch pathways are related to
EndoMT [4, 6]. For example, EndoMT in CCM1-ablated
endothelial cells is mediated by the activation of the
TGF-β and BMP signaling pathways; moreover, inhibi-
tors of the TGF-β and BMP pathways prevent EndoMT
both in vitro and in vivo [25]. Further, the TGF-β
pathway-induced inhibition of EndoMT reduced renal
fibrosis and retarded the progression of nephropathy
[26]. Studies have demonstrated that TGF-β stimulates
EndMT through the Smad, p38 MAPK signalling path-
ways. These pathways are essential for increasing the
expression of the cell-adhesion-suppressing transcription
factor Snail [27]. Snail is best known for its ability to
trigger EndMT. In this study, we found strong Snail ex-
pression in 5/6 Nx rats. However, Snail expression was
much lower in the Ad-netrin-1-treated 5/6 Nx rats.
Therefore, we propose that netrin-1 might inhibit
EndoMT by blocking the TGF-β/Snail/α-SMA signal-
ing pathway.
Recent studies report that netrin-1 protects the kid-
ney against ischemia-reperfusion injury and attenuates
diabetic kidney disease [28]. This indicates the pro-
tective role of the anti-inflammatory molecule netrin-
1 in diabetic kidney disease; in particular, specific
overexpression of netrin-1 in proximal tubular epithe-
lial cells suppressed inflammation and albuminuria
[29]. These findings suggest that netrin-1 suppresses
kidney inflammation by inhibiting the cyclooxygenase-
2 (COX-2)-mediated production of prostaglandin E2
Fig. 5 ELISA study to determine the concentration of TGF-β. Analyses were additionally performed at postsurgery weeks 7 and 12. Data are presented
as mean ± SEM). *, P < 0.05 vs. sham; #, P < 0.05 vs. 5/6 Nx
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(PGE2) in AKI and streptozotocin-induced diabetic
mice [30]. Netrin-1 also suppressed AKI-induced tubular
atrophy, interstitial fibrosis, vascular dropout, and glom-
erular sclerosis through suppression of STAT3 and JNK
signaling and IL-6 expression in tubular epithelial cells
[31]. Therefore, several pathways and factors may play a
role in the anti-fibrotic effect of netrin-1. Based on our
findings, further studies are needed to elucidate the signal
pathway underlying the effect of netrin-1 in EndoMT-
mediated protection of the kidney.
Conclusions
EndoMT contributes to renal fibrosis in 5/6 Nx rats and
can be prevented by netrin-1 treatment. These results
imply that netrin-1 might exert its protective role in pre-
venting CKD via an EndoMT-inhibiting mechanism.
Netrin-1 may inhibit EndoMT by blocking the TGF-β/
Snail/signaling pathway. Our results suggest that netrin-
1 may represent a potential therapeutic agent for treat-
ing interstitial fibrosis. Further, the EndoMT-inhibiting
mechanism in the kidney may also indicate its role in
the prevention of renal disease progression.
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